Correlation Between Opthea and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Opthea and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and Immix Biopharma, you can compare the effects of market volatilities on Opthea and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Immix Biopharma.
Diversification Opportunities for Opthea and Immix Biopharma
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Opthea and Immix is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Opthea i.e., Opthea and Immix Biopharma go up and down completely randomly.
Pair Corralation between Opthea and Immix Biopharma
Considering the 90-day investment horizon Opthea is expected to generate 1.63 times more return on investment than Immix Biopharma. However, Opthea is 1.63 times more volatile than Immix Biopharma. It trades about 0.0 of its potential returns per unit of risk. Immix Biopharma is currently generating about -0.08 per unit of risk. If you would invest 387.00 in Opthea on December 28, 2024 and sell it today you would lose (46.00) from holding Opthea or give up 11.89% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 90.0% |
Values | Daily Returns |
Opthea vs. Immix Biopharma
Performance |
Timeline |
Opthea |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Immix Biopharma |
Opthea and Immix Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Opthea and Immix Biopharma
The main advantage of trading using opposite Opthea and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.Opthea vs. Molecular Partners AG | Opthea vs. MediciNova | Opthea vs. Anebulo Pharmaceuticals | Opthea vs. Champions Oncology |
Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |